PREVAIL Begins Vaccinations in the Phase 2a Lassa Fever Vaccine Study
MONROVIA – On May 13, 2024, participants in Monrovia, Liberia, were vaccinated with a Lassa fever vaccine candidate as part ...
Tag: Merck’s Zaire ebolavirus
© 2024 THE LIBERIAN INVESTIGATOR, All Rights Reserved And subject to Terms of Use Agreement.